This report contains market size and forecasts of Immune Cell Therapy in Global, including the following market information:
Global Immune Cell Therapy Market Size 2024-2032, ($ millions)
The global Immune Cell Therapy market is projected to reach US$ million by 2032.
We surveyed the Immune Cell Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Immune Cell Therapy Market, by Type, 2024-2032 ($ millions)
Global Immune Cell Therapy Market Segment Percentages, by Type
T Cell Therapy
Natural Killer (NK) Cell Therapy
Other
Global Immune Cell Therapy Market, by Application, 2024-2032 ($ millions)
Global Immune Cell Therapy Market Segment Percentages, by Application
Stomach Cancer
Lung Cancer
Colorectal Cancer
Esophageal Cancer
Pancreatic Cancer
Other
Global Immune Cell Therapy Market, By Region and Country, 2024-2032 ($ Millions)
Global Immune Cell Therapy Market Segment Percentages, by region and country
United States
Europe
Asia
China
Rest of World
Competitor Analysis
The report also provides analysis of leading market participants including:
Further, the report presents profiles of competitors in the market, key players include:
Adaptimmune
Altor Bioscience Corporation
Cellectis
Juno Therapeutics
Kite Pharma
Novartis
Takara Bio
Unum Therapeutics
